IMCD N.V. (IMCD.VI)
| Previous close | 142.05 |
| Open | 138.85 |
| Bid | 0.00 x N/A |
| Ask | 0.00 x N/A |
| Day's range | 138.85 - 138.85 |
| 52-week range | 111.65 - 168.05 |
| Volume | |
| Avg. volume | 3 |
| Market cap | 7.907B |
| Beta (5Y monthly) | 1.06 |
| PE ratio (TTM) | 27.12 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 2.24 (1.61%) |
| Ex-dividend date | 16 May 2024 |
| 1y target est | N/A |
- GlobeNewswire
IMCD Italy expands its Pharmaceuticals presence with the acquisition of Selechimica
IMCD_logo Logo IMCD ROTTERDAM, The Netherlands (10 June 2024) – IMCD N.V. (“IMCD” or “Company”), a leading distributor of speciality chemicals and ingredients, today announces that IMCD Italy has signed an agreement to acquire 100% of the shares in Selechimica S.R.L. (“Selechimica”), an Italian distributor in the pharmaceutical industry. Headquartered in Milan, Italy, Selechimica distributes an extensive portfolio of Active Pharmaceutical Ingredients (APIs). With 3 employees, Selechimica represe
- Business Wire
Nu-Tek BioSciences Inks Deal with IMCD for Distribution – Expands Global Reach in Europe & APAC Regions
MINNETONKA, Minn., June 04, 2024--Nu-Tek has executed an agreement with IMCD for distribution of its peptones and hydrolysates into Europe & Asia Pacific.
- GlobeNewswire
Shareholders IMCD N.V. adopt all resolutions at AGM
IMCD_logo Logo IMCD ROTTERDAM, The Netherlands (14 May 2024, 17:00 hrs CEST) – IMCD N.V. ("IMCD" or "Company"), a global leading distribution partner, formulator of speciality chemicals and ingredients, announces that all resolutions proposed to the shareholders Annual General Meeting of shareholders (AGM) held today were adopted. Turn-out was high, with almost 88% of shareholder represented. The resolutions included adoption of the financial statements for the year 2023 and approval of the divi
